Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout mice
- 20 May 2003
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 41 (10) , 1812-1819
- https://doi.org/10.1016/s0735-1097(03)00304-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2Science, 2002
- Serum of Cytomegalovirus‐Infected Mice Induces Monocyte Chemoattractant Protein–1 Expression by Endothelial CellsThe Journal of Infectious Diseases, 2001
- Why there are two cyclooxygenase isozymesJournal of Clinical Investigation, 2001
- Atherosclerosis in apoE Knockout Mice Infected with Multiple PathogensThe Journal of Infectious Diseases, 2001
- COX-2 and the cyclopentenone prostaglandins - a new chapter in the book of inflammation?Prostaglandins & Other Lipid Mediators, 2000
- Cytomegalovirus in the pathogenesis of atherosclerosisJournal of the American College of Cardiology, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Pertussis toxin-sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells.Journal of Clinical Investigation, 1997
- Antiviral activity of cyclopentenone prostanoidsTrends in Microbiology, 1997
- Mouse Models of AtherosclerosisScience, 1996